Prediction of organ involvement and survival in systemic sclerosis patients in the first 5years from diagnosis

被引:13
作者
van den Hombergh, Wieneke M. T. [1 ]
Knaapen-Hans, Hanneke K. A. [1 ]
van den Hoogen, Frank H. J. [1 ]
Carreira, Patricia [2 ]
Distler, Oliver [3 ]
Hesselstrand, Roger [4 ]
Hunzelmann, Nicolas [5 ]
Vettori, Serena [6 ]
Fransen, Jaap [1 ]
Vonk, Madelon C. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Route 470,POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] Univ Hosp 12 Octubre, Dept Rheumatol, Madrid, Spain
[3] Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland
[4] Lund Univ, Dept Rheumatol, Lund, Sweden
[5] Univ Cologne, Dept Dermatol, Cologne, Germany
[6] Univ Campania Luigi Vanvitelli, Dept Rheumatol, Naples, Italy
关键词
Systemic sclerosis; organ involvement; survival; interstitial lung disease; pulmonary hypertension; PULMONARY ARTERIAL-HYPERTENSION; EULAR SCLERODERMA TRIALS; RISK-FACTORS; DISEASE; GUIDELINES; MANAGEMENT; MORTALITY; MODELS; DEATH;
D O I
10.1177/2397198319869564
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Organ involvement often occurs in early systemic sclerosis and has been related to premature death. Identifying patients at diagnosis at risk of developing early organ involvement would be useful to optimize screening and management strategies. Objective: To develop prediction models for the 5-year development of interstitial lung disease, pulmonary arterial hypertension and death. Methods: A European multicentre inception cohort was created. For modelling, predefined clinical variables with known predictive value at diagnosis were used. Univariate and multivariate regression analysis were done to select baseline predictors and build the prediction models. The models were tested using the area under the receiver operating characteristic curve comparing observed and expected frequencies. Results: Of 735 patients, 23% developed interstitial lung disease, 8% developed pulmonary arterial hypertension 12% died. The interstitial lung disease model included diffuse cutaneous systemic sclerosis (OR = 1.8), systemic sclerosis disease duration<3years (OR = 1.4), puffy fingers (OR = 1.6), and anti-topoisomerase-I-antibodies (OR = 1.8). The pulmonary arterial hypertension model included age>65years (OR = 3.2), forced vital capacity<70% (OR = 2.5) and diffusing capacity of the lung for carbon monoxide<55% (OR = 1.9). Death was predicted best by age>65years (OR = 4.1), male gender (OR = 1.9), no anti-centromere antibodies (OR = 0.5), proteinuria (OR = 1.9), forced vital capacity<70% (OR = 1.8) and pulmonary arterial hypertension at diagnosis (OR = 10.1). The area under the receiver operating characteristic was 0.66 (95% CI 0.64-0.67), 0.66 (95% CI 0.64-0.68) and 0.70 (95% CI 0.69-0.72), respectively. Conclusion: We have shown that it is possible to predict interstitial lung disease, pulmonary arterial hypertension and death using established variables already available at the moment of systemic sclerosis diagnosis. Discriminatory performance of the models was suboptimal. Further research including new variables is necessary to improve performance.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 31 条
  • [1] Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada
    Al-Dhaher, Firas F.
    Pope, Janet E.
    Ouimet, Janine M.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (04) : 269 - 277
  • [2] Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
    Assassi, Shervin
    Sharif, Roozbeh
    Lasky, Robert E.
    McNearney, Terry A.
    Estrada-Y-Martin, Rosa M.
    Draeger, Hilda
    Nair, Deepthi K.
    Fritzler, Marvin J.
    Reveille, John D.
    Arnett, Frank C.
    Mayes, Maureen D.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (05)
  • [3] Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study
    Avouac, Jerome
    Walker, Ulrich A.
    Hachulla, Eric
    Riemekasten, Gabriela
    Cuomo, Giovanna
    Carreira, Patricia E.
    Caramaschi, Paola
    Ananieva, Lidia P.
    Matucci-Cerinic, Marco
    Czirjak, Laszlo
    Denton, Christopher
    Ladner, Ulf Mueller
    Allanore, Yannick
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) : 103 - 109
  • [4] Beretta L, 2010, CLIN EXP RHEUMATOL, V28, pS18
  • [5] Beretta L, 2011, EXPERT REV CLIN IMMU, V7, P391, DOI [10.1586/eci.11.33, 10.1586/ECI.11.33]
  • [6] Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
    Coghlan, J. Gerry
    Denton, Christopher P.
    Gruenig, Ekkehard
    Bonderman, Diana
    Distler, Oliver
    Khanna, Dinesh
    Mueller-Ladner, Ulf
    Pope, Janet E.
    Vonk, Madelon C.
    Doelberg, Martin
    Chadha-Boreham, Harbajan
    Heinzl, Harald
    Rosenberg, Daniel M.
    McLaughlin, Vallerie V.
    Seibold, James R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) : 1340 - 1349
  • [7] Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
    Denton, C. P.
    Hachulla, E.
    [J]. EUROPEAN RESPIRATORY REVIEW, 2011, 20 (122) : 270 - 276
  • [8] Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres
    Fransen, J.
    Popa-Diaconu, D.
    Hesselstrand, R.
    Carreira, P.
    Valentini, G.
    Beretta, L.
    Airo, P.
    Inanc, M.
    Ullman, S.
    Balbir-Gurman, A.
    Sierakowski, S.
    Allanore, Y.
    Czirjak, L.
    Riccieri, V.
    Giacomelli, R.
    Gabrielli, A.
    Riemekasten, G.
    Matucci-Cerinic, M.
    Farge, D.
    Hunzelmann, N.
    Van den Hoogen, F. H. J.
    Vonk, M. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) : 1788 - 1792
  • [9] Guidelines on diagnosis and treatment of pulmonary arterial hypertension -: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
    Galiè, N
    Torbicki, A
    Barst, R
    Dartevelle, P
    Haworth, S
    Higenbottam, T
    Olschewski, H
    Peacock, A
    Pietra, G
    Rubin, LJ
    Simonneau, G
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (24) : 2243 - 2278
  • [10] How many imputations are really needed? - Some practical clarifications of multiple imputation theory
    Graham, John W.
    Olchowski, Allison E.
    Gilreath, Tamika D.
    [J]. PREVENTION SCIENCE, 2007, 8 (03) : 206 - 213